GILD Dividend: Gilead Sciences, Inc Yield Insights

According to the latest financial statement (Form-10K), Gilead Sciences, Inc has a total asset of $59,023, Net profit of $8,510

Gilead Sciences, Inc's Current ratio is 1.62, has a Net margin is 28.9, sales per share of $23.46.

Currently Gilead Sciences, Inc data is not available.

yes, according to the latest financial statements, Gilead Sciences, Inc has a net profit of $8,510

yes, Gilead Sciences, Inc has liability of 36,321

Gilead Sciences, Inc has a total outstanding shares of 1,241

Edgen AI operates independently of, and is not controlled by Aspen Digital Financial Limited.

GILD Dividend: Gilead Sciences, Inc Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

GILD Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Revenue	29,736	29,443	28,754	27,116	27,281	27,305
Revenue Growth (YoY)	3%	2%	6%	-1%	0%	11%
Cost of Revenue	6,139	6,230	6,251	6,019	5,657	6,601
Gross Profit	23,597	23,213	22,503	21,097	21,624	20,704
Selling, General & Admin	5,913	5,708	5,933	5,537	5,267	5,246
Research & Development	5,745	5,731	5,742	5,698	4,977	5,363
Operating Expenses	11,657	11,439	11,675	11,235	10,244	10,609
Other Non Operating Income (Expenses)	79	-2	-2	-11	76	-29
Pretax Income	10,728	9,796	690	6,859	5,814	8,278
Income Tax Expense	1,511	1,286	211	1,247	1,248	2,077
Net Income	9,216	8,510	480	5,665	4,592	6,225
Net Income Growth	55%	1,673%	-92%	23%	-26%	4,961%
Shares Outstanding (Diluted)	1,254	1,255	1,255	1,258	1,262	1,262
Shares Change (YoY)	0%	0%	0%	0%	0%	0%
EPS (Diluted)	7.34	6.78	0.38	4.5	3.64	4.93
EPS Growth	56%	1,684%	-92%	24%	-26%	4,830%
Free Cash Flow	10,018	9,455	10,305	7,421	8,344	10,805
Free Cash Flow Per Share	7.98	7.53	8.21	5.89	6.61	8.56
Gross Margin	79.35%	78.84%	78.26%	77.8%	79.26%	75.82%
Operating Margin	40.15%	39.98%	37.65%	36.36%	41.71%	36.97%
Profit Margin	30.99%	28.9%	1.66%	20.89%	16.83%	22.79%
Free Cash Flow Margin	33.68%	32.11%	35.83%	27.36%	30.58%	39.57%
EBITDA	16,080	14,534	13,595	12,555	13,483	12,145
EBITDA Margin	54.07%	49.36%	47.28%	46.3%	49.42%	44.47%
D&A For EBITDA	4,140	2,760	2,767	2,693	2,103	2,050
EBIT	11,940	11,774	10,828	9,862	11,380	10,095
EBIT Margin	40.15%	39.98%	37.65%	36.36%	41.71%	36.97%
Effective Tax Rate	14.08%	13.12%	30.57%	18.18%	21.46%	25.09%











